REJURAN® COSMETICS Expands U.S. Retail Presence Through Costco's First-Ever Beauty Table Program
REJURAN® COSMETICS Expands U.S. Retail Presence Through Costco's First-Ever Beauty Table Program
PR Newswire
SEOUL, South Korea, Oct. 23, 2026
The premium Korean skincare brand introduces a Costco member set featuring its c-PDRN®-powered Turnover Ampoule
SEOUL, South Korea, Oct. 23, 2026 /PRNewswire/ -- REJURAN® COSMETICS is expanding its U.S. retail presence through Costco's new Beauty Table program, bringing its c-PDRN® skincare to more American shoppers. The premium dermocosmetics brand was developed by PharmaResearch, the biopharmaceutical company behind the globally recognized REJURAN® skin booster.
Currently operating in 25 U.S. warehouses, the dedicated beauty display program is designed to help Costco members discover beauty brands and products while shopping. REJURAN® COSMETICS will showcase its brand and key products through the program, with plans to expand its participation to more than 150 U.S. warehouses.
For the program, the brand is introducing a Costco-exclusive REJURAN® Turnover Ampoule set, pairing a 50 mL full-size bottle with an additional 10 mL, offering added value for members. Formulated with c-PDRN®, the company's proprietary ingredient developed specifically for cosmetic use, the daily skincare ampoule helps hydrate skin and improve texture.
The launch broadens the brand's U.S. distribution and makes its products more accessible to both existing customers and shoppers discovering REJURAN® COSMETICS for the first time. Building on Costco's membership base and warehouse network, the brand plans to use local consumer feedback and demand to inform future product assortments and marketing initiatives.
"Costco's Beauty Table program offers an exciting opportunity to introduce our c-PDRN® skincare to more U.S. consumers," said Jooyeon Song, Head of Cosmetics at PharmaResearch USA. "We will continue expanding our product offerings and retail presence to reflect the needs of American shoppers and bring the REJURAN® COSMETICS experience to a wider audience."
About PharmaResearch and REJURAN® COSMETICS
PharmaResearch is a pioneering South Korean biopharmaceutical company dedicated to enhancing quality of life through regenerative medicine. Its portfolio spans medicines, medical devices, cosmetics and health supplements, built around its core DOT® PDRN and PN technologies, which are protected by multiple patents. PharmaResearch is headquartered in Gangneung, South Korea.
The company is behind REJURAN®, its globally recognized PN-based skin booster available in more than 50 countries, and REJURAN® COSMETICS, its premium derma-cosmetic brand. Drawing on PharmaResearch's expertise in PN- and PDRN-based technologies and skin science, REJURAN® COSMETICS combines proprietary DOT® c-PDRN® technology with advanced cosmetic formulations designed to support healthy-looking skin, hydration, and elasticity.
REJURAN® COSMETICS continues to expand across major global beauty markets, including North America, as demand grows for science-driven Korean skincare.
To learn more and shop REJURAN® COSMETICS, visit rejurancosmetics.com.
SOURCE PharmaResearch
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
United States